GSK gets US green light for two-drug HIV treatment
9th Apr 2019 07:29
(Sharecast News) - GlaxoSmithkline said its two drug HIV treatment had been granted US market approval.
Read moreFriday broker round-up
5th Apr 2019 12:53
(Sharecast News) - Purplebricks: Berenberg downgrades to sell with a target price of 80p.
Read moreGSK monthly HIV treatment meets targets
8th Mar 2019 07:17
(Sharecast News) - Two late-stage clinical trials by GlaxoSmithKline's ViiV Healthcare joint venture of its novel, investigational, long-acting HIV treatment have both met their primary aims.
Read moreTobacco stocks rise after FDA boss Gottlieb quits
6th Mar 2019 09:20
(Sharecast News) - Shares in tobacco companies rose on Wednesday after America's chief drug and tobacco regulator unexpectedly resigned overnight.
Read moreViiV Healthcare to collaborate with Dutch university medical center
26th Feb 2019 12:37
(Sharecast News) - GlaxoSmithKline owned ViiV Healthcare announced on Tuesday a new five-year collaboration with Radboud university medical center in The Netherlands to identify new drug targets for HIV.
Read morePharma firms to testify in Congress over drug pricing
26th Feb 2019 08:31
(Sharecast News) - Top executives of pharmaceutical companies are set to testify in front of the Senate Finance Committee on Tuesday as part of an investigation into drug pricing in the US.
Read moreGSK 'likely' to face HIV sales slowdown, UBS downgrades
22nd Feb 2019 16:19
(Sharecast News) - UBS thinks GSK shares will struggle to perform in the near-term if there is nervousness around its ViiV HIV business.
Read moreFriday broker round-up
22nd Feb 2019 13:01
(Sharecast News) - Codemasters Group Holding: Berenberg upgrades to buy with a target price of 260p.
Read moreSFO closes Rolls-Royce and GSK investigations
22nd Feb 2019 12:11
(Sharecast News) - The Serious Fraud Office has closed its investigations into alleged bribery at GlaxoSmithKline and Rolls-Royce, it said on Friday.
Read moreDirector dealings: GSK director ups stake
14th Feb 2019 15:34
(Sharecast News) - GlaxoSmithKline director Victoria Whyte acquired £47,000 worth of ordinary shares in the UK's biggest drugs company on Thursday.
Read moreDirector dealings: GSK executive lowers stake
12th Feb 2019 15:31
(Sharecast News) - GlaxoSmithKline company Victoria Whyte disposed of 5,199 ordinary shares in the UK's biggest drugs company on Tuesday.
Read moreMonday broker round-up
11th Feb 2019 13:38
(Sharecast News) - Metro Bank: Berenberg upgrades to hold with a target price of 1,200p.
Read moreThursday broker round-up
7th Feb 2019 13:20
(Sharecast News) - EI Group: Peel Hunt downgrades to hold with a target price of 215p.
Read moreWednesday broker round-up
6th Feb 2019 13:31
(Sharecast News) - National Grid: RBC Capital Markets upgrades to outperform with a target price of 950p.
Read moreGSK posts healthy full-year numbers but trims 2019 forecasts
6th Feb 2019 10:33
(Sharecast News) - GlaxoSmithKline reported full-year sales of more than £30bn on Wednesday, but warned that earnings in the current year would be hurt by generic competition to its blockbuster asthma treatment.
Read more